Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
IGI Laboratories, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's... 
Sector
Pharmaceuticals
Calendar
03/09 | 12:30pmPresentation
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 57,7 M
EBIT 2015 8,56 M
Net income 2015 10,0 M
Debt 2015 -
Yield 2015 -
Sales 2016 88,7 M
EBIT 2016 23,4 M
Net income 2016 20,9 M
Debt 2016 -
Yield 2016 -
PER 2015 123,30
PER 2016 42,76
Capi. / Sales 2015 9,79x
Capi. / Sales 2016 6,37x
Capitalization 565 M
More Financials
Latest news on IGI LABORIGI
03/02 IGI LABORATORIES : Announces Fourth Quarter And Year End 2014 Results
02/27 IGI LABORATORIES : To Hold Conference Call For 4th Quarter 2014 Results
02/06 IGI LABORATORIES : To Hold Conference Call For 4th Quarter 2014 Results
01/26 Questions raised over Swiss franc retail trades
01/08 IGI LABORATORIES : To Present At 33rd Annual J.P. Morgan Healthcare Conference O..
2014 IGI LABORATORIES : Announces Three Additional ANDA Submissions
2014 IGI LABORATORIES : Announces Closing of Initial Purchasers' Exercise in Full of ..
2014 IGI LABORATORIES : Consumer Staples Industry Equities under the Scanner -- Proct..
More news
Sector news Pharmaceuticals - NEC
03/05 JOHNSON & JOHNSON : Local woman wins $5.7 million in lawsuit against Johnson & J..
03/05DJBiotech Bidding War Yields Rich Price
03/05DJForeign Takeovers See U.S. Losing Tax Revenue
Plus d'actualités du secteur Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF